Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial.

Circulation · 2021 · PMC8522627 · PMID 34459213

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

nearly significantP =0.06so close (0.05 < p ≤ 0.1)

This treatment difference was nearly significant at week 4 ( P =0.06) and was statistically significant at all time points from 12 weeks through 148 weeks after randomization (Table 3 ).

also in 3,287 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.